42 APPARENT: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Iptacopan in Idiopathic (primary) Immune Complex-Mediated Membranoproliferative Glomerulonephritis
Immunobiology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要